Results 181 to 190 of about 6,309 (194)

Heterogeneous worldwide access and pricing of Tafamidis

Amyloid, 2023
Abdirahman, Wardhere, Dimitrios, Bampatsias, Nowell, Fine, Pablo, Garcia-Pavia, Martha, Grogan, Arnt V, Kristen, Thibaud, Damy, Yoshiki, Sekijima, Mathew S, Maurer   +8 more
openaire   +2 more sources

Tafamidis-meglumine

Reactions Weekly
  +4 more sources

Rosuvastatin/tafamidis meglumine interaction

Reactions Weekly, 2022
openaire   +1 more source

Amiodarone/atorvastatin/tafamidis meglumine interaction

Reactions Weekly, 2021
openaire   +1 more source

Tafamidis in Octogenarians

JACC: Heart Failure
Joshua D. Mitchell, Michael W. Rich
openaire   +1 more source

TAFAMIDIS: THE COST TO OUR PATIENTS

Journal of the American College of Cardiology, 2020
Jan Griffin, Margaret Cuomo, Samantha Guadalupe, Danilo Gamino, Sergio Teruya, Sunil Saith, Hannah Rosenblum, Melissa Valarezo, Stephen Helmke, Mathew Maurer   +9 more
openaire   +1 more source

Summary of opinion: Vyndaqel,tafamidis

Case Medical Research, 2019
openaire   +2 more sources

Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy

JAMA, 2020
openaire   +2 more sources

Zulassungserweiterung und vielversprechende Langzeitdaten für Tafamidis

DNP - Der Neurologe & Psychiater, 2020
openaire   +1 more source

10-Jahres-Überlebensdaten zu Tafamidis

InFo Neurologie & Psychiatrie, 2014
openaire   +1 more source